Method of treating atherosclerotic occlusive disease

US9974670B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9974670-B2
Application numberUS-201113246776-A
CountryUS
Kind codeB2
Filing dateSep 27, 2011
Priority dateDec 12, 2007
Publication dateMay 22, 2018
Grant dateMay 22, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A tack device for holding plaque against blood vessel walls in treating atherosclerotic occlusive disease can be formed as a thin, annular band of durable, flexible material. The tack device may also have a plurality of barbs or anchoring points on its outer annular periphery. The annular band can have a length in the axial direction of the blood vessel walls that is about equal to or less than its diameter as installed in the blood vessel. A preferred method is to perform angioplasty with a drug eluting balloon as a first step, and if there is any dissection to the blood vessel caused by the balloon angioplasty, one or more tack devices may be installed to tack down the dissected area of the blood vessel surface, in order to avoid the need to install a stent and thereby maintain a ‘stent-free’ environment.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of treating atherosclerotic occlusive disease in a blood vessel comprising: positioning a guide wire across a blockage or narrowing in the blood vessel; advancing a drug eluting balloon (DEB) over the guide wire to the blockage or narrowing in the blood vessel; inflating and then deflating the DEB at the blockage or narrowing in the blood vessel thereby creating an expanded area of the blood vessel, inflating further comprising creating a dissection in a blood vessel surface; removing the DEB from the blood vessel; advancing a delivery catheter loaded with multiple self-expanding Nitinol tacks to the treatment area; independently deploying two or more self-expanding Nitinol tacks from the delivery catheter at the discretion of an operator to treat the dissection in the blood vessel surface creating a treatment area, such that a vessel coverage area (C) of the deployed two or more self-expanding Nitinol tacks divided by a Total Vessel Surface Area (TVS) of the treatment area has a ratio (C/TVS) of less than or equal to 60%, wherein the vessel coverage area is based on summation of an axial length measured from a distal-most end to a proximal-most end for each of the deployed two or more self-expanding Nitinol tacks, and the Total Vessel Surface Area is based on a distance from a distal-most end to a proximal-most end of the treatment area having the dissection in the blood vessel surface; positioning a balloon at the site of the deployed two or more self-expanding Nitinol tacks; and inflating the balloon to further expand the deployed two or more self-expanding Nitinol tacks into a wall of the blood vessel. 2. The method of claim 1 , wherein deploying two or more self-expanding Nitinol tacks from the delivery catheter further comprises deploying the two or more self-expanding Nitinol tacks such that the ratio (C/TVS) is less than or equal to 50%. 3. The method of claim 1 , wherein deploying two or more self-expanding Nitinol tacks from the delivery catheter further comprises deploying each tack such that they do not overlap with any adjacent tack. 4. The method of claim 1 , wherein deploying two or more self-expanding Nitinol tacks from the delivery catheter further comprises deploying each self-expanding Nitinol tack at least one tack axial length apart from any adjacent self-expanding Nitinol tack. 5. The method of claim 1 , further comprising delivering medication to the blood vessel with one or more of the deployed two or more self-expanding Nitinol tacks. 6. The method of claim 1 , wherein a ratio of axial length to a diameter (L/D) for each self-expanding Nitinol tack is equal to or less than 1. 7. The method of claim 1 , further comprising engaging the wall of the blood vessel with a barb or anchor on each of the deployed two or more self-expanding Nitinol tacks to maintain a locking relationship between the tack and the wall. 8. The method of claim 7 , wherein engaging the wall of the blood vessel further comprises piercing the wall with the barb or anchor. 9. The method of claim 1 , wherein a spacing of the tacks in the vessel is different than a spacing of the tacks in the delivery catheter. 10. The method of claim 1 , wherein each self-expanding Nitinol tack comprises concentric rings connected by a series of bridging members and deploying two or more self-expanding Nitinol tacks from the delivery catheter further comprises self-expanding the concentric rings. 11. A method of treating a blood vessel comprising: advancing a first balloon to a blockage or narrowing in the blood vessel; inflating and then deflating the first balloon at the blockage or narrowing in the blood vessel thereby creating an expanded area, the expanded area further having a treatment area defined by a dissection in the blood vessel surface; removing the first balloon from the blood vessel; advancing a delivery catheter including multiple independently deployable implants to the treatment area; and deploying two or more implants from the delivery catheter to treat the dissection in the blood vessel surface at the treatment area, such that a vessel coverage area (C) of the deployed two or more implants divided by a Total Vessel Surface Area (TVS) of the treatment area has a ratio (C/TVS) of less than or equal to 60%, wherein the vessel coverage area is based on summation of an axial length measured from a distal-most end to a proximal-most end for each of the deployed two or more implants, and the Total Vessel Surface Area is based on a distance from a distal-most end to a proximal-most end of the treatment area having the dissection in the blood vessel surface. 12. The method of claim 11 , wherein deploying two or more implants from the delivery catheter further comprises deploying the two or more implants such that the ratio (C/TVS) is less than or equal to 50%. 13. The method of claim 11 , wherein deploying two or more implants from the delivery catheter further comprises deploying each implant of the two or more implants such that they do not overlap with any adjacent implant of the two or more implants. 14. The method of claim 11 , wherein deploying two or more implants from the delivery catheter further comprises deploying each implant at least one implant axial length apart from any adjacent implant. 15. The method of claim 11 , wherein deploying two or more implants from the delivery catheter further comprises releasing two or more self-expanding Nitinol implants from the delivery catheter and allowing the two or more self-expanding Nitinol implants to self-expand. 16. The method of claim 11 , further comprising delivering medication to the blood vessel with one or more of the deployed two or more implants. 17. The method of claim 11 , wherein advancing a first balloon to the blockage or narrowing in the blood vessel further comprises advancing a drug eluting balloon to the blockage or narrowing in the blood vessel. 18. The method of claim 11 , further comprising positioning a second balloon at the treatment site and inflating the second balloon to further expand the deployed two or more implants. 19. The method of claim 11 , wherein deploying two or more implants from the delivery catheter further comprises releasing two or more polymer implants. 20. The method of claim 19 , wherein deploying two or more implants from the delivery catheter further comprises releasing two or more polymer implants from the delivery catheter and allowing the two or more polymer implants to self-expand. 21. The method of claim 19 , wherein deploying two or more implants from the delivery catheter further comprises releasing at least one polymer implant consisting of polyglycolic acid from the delivery catheter. 22. The method of claim 11 , wherein a ratio of the axial length to a diameter (L/D) for each implant is equal to or less than 1. 23. The method of claim 11 , further comprising engaging tissue of the blood vessel with a barb or anchor on each of the deployed two or more implants. 24. The method of claim 23 , wherein engaging tissue of the blood vessel further comprises piercing the tissue with the barb or anchor. 25. The method of claim 11 , wherein a spacing of the implants in the blood vessel is different than a spacing of the implants in the delivery catheter. 26. The method of claim 11 , wherein each implant comprises concentric rings connected by a series of bridging members

Assignees

Inventors

Classifications

  • Inflatable balloons for placing stents or stent-grafts · CPC title

  • Stents, different from stent-grafts, adapted to cover an aneurysm · CPC title

  • folded prior to deployment · CPC title

  • having longitudinal struts · CPC title

  • Instruments specially adapted for placement or removal of stents or stent-grafts · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9974670B2 cover?
A tack device for holding plaque against blood vessel walls in treating atherosclerotic occlusive disease can be formed as a thin, annular band of durable, flexible material. The tack device may also have a plurality of barbs or anchoring points on its outer annular periphery. The annular band can have a length in the axial direction of the blood vessel walls that is about equal to or less than…
Who is the assignee on this patent?
Schneider Peter, Giasolli Robert, Intact Vascular Inc
What technology area does this patent fall under?
Primary CPC classification A61F2/86. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 10 related publications on this page (citations in our corpus or others sharing the same primary CPC).